Zelira Therapeutics Limited (ZLD.AX)
AUD 0.62
(1.64%)
AUD 0.62
(1.64%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 5.65 Million AUD | 1258.55% |
| 2023 | 437.9 Thousand AUD | -12.58% |
| 2022 | 500.9 Thousand AUD | -9.1% |
| 2021 | 551.08 Thousand AUD | -12.85% |
| 2020 | 632.32 Thousand AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | -100.0% |
| 2016 | 1 Million AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | -100.0% |
| 2009 | 798.36 Thousand AUD | 0.0% |
| 2008 | - AUD | -100.0% |
| 2007 | 3.31 Million AUD | 10.42% |
| 2006 | 3 Million AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 5.65 Million AUD | 0.0% |
| 2024 Q2 | 1.72 Million AUD | 0.0% |
| 2024 FY | 3.83 Million AUD | 775.91% |
| 2023 FY | 437.9 Thousand AUD | -12.58% |
| 2023 Q2 | 494.19 Thousand AUD | 0.0% |
| 2023 Q4 | 437.9 Thousand AUD | 0.0% |
| 2022 Q2 | 533.76 Thousand AUD | 0.0% |
| 2022 Q4 | 500.9 Thousand AUD | 0.0% |
| 2022 FY | 500.9 Thousand AUD | -9.1% |
| 2021 Q2 | 523.5 Thousand AUD | 0.0% |
| 2021 Q4 | 551.08 Thousand AUD | 0.0% |
| 2021 FY | 551.08 Thousand AUD | -12.85% |
| 2020 Q2 | 24.94 Thousand AUD | 0.0% |
| 2020 FY | 632.32 Thousand AUD | 0.0% |
| 2020 Q4 | 632.32 Thousand AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | -100.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q2 | 211.07 Thousand AUD | 0.0% |
| 2016 Q4 | 1 Million AUD | 0.0% |
| 2016 FY | 1 Million AUD | 0.0% |
| 2016 Q2 | 250 Thousand AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | -100.0% |
| 2009 Q4 | 798.36 Thousand AUD | 0.0% |
| 2009 FY | 798.36 Thousand AUD | 0.0% |
| 2008 FY | - AUD | -100.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 FY | 3.31 Million AUD | 10.42% |
| 2007 Q4 | 3.31 Million AUD | 0.0% |
| 2006 FY | 3 Million AUD | 0.0% |
| 2006 Q4 | 3 Million AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -4464.569% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Biome Australia Limited | 1.3 Million AUD | -332.979% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | -719.711% |
| Imugene Limited | 1.54 Million AUD | -265.466% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | -408.046% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | -1610.66% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -1686.846% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.969% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | -542.6% |
| Starpharma Holdings Limited | 3.52 Million AUD | -60.246% |
| Nanollose Limited | 42.53 Thousand AUD | -13192.951% |
| Memphasys Limited | 4.41 Million AUD | -28.105% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | -262.004% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | -1239.792% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 67.592% |
| Dimerix Limited | 149.68 Thousand AUD | -3676.977% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | -360.282% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -3454.649% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | -280.194% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -79191.613% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | -126.633% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -23863.598% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -2262.216% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | -596.938% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -3127.782% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -1671.871% |
| Immuron Limited | 173.49 Thousand AUD | -3158.553% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |